Eledon Pharmaceuticals, Inc. (ELDN)
Largest Insider Buys in Sector
ELDN Stock Price History Chart
ELDN Stock Performance
About Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Insider Activity of Eledon Pharmaceuticals, Inc.
Over the last 12 months, insiders at Eledon Pharmaceuticals, Inc. have bought $4.57M and sold $0 worth of Eledon Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Eledon Pharmaceuticals, Inc. have bought $2.91M and sold $2.57M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BVF PARTNERS L P/IL (10 percent owner) — $86.82M.
The last purchase of 1,927,937 shares for transaction amount of $4.57M was made by BVF PARTNERS L P/IL (10 percent owner) on 2024‑05‑09.
List of Insider Buy and Sell Transactions, Eledon Pharmaceuticals, Inc.
| 2024-05-09 | BVF PARTNERS L P/IL | 10 percent owner | 1.93M 7.8677% | $2.37 | $4.57M | +17.30% | ||
| 2023-05-05 | BVF PARTNERS L P/IL | 10 percent owner | 1.98M 11.9399% | $2.31 | $4.57M | -41.42% | ||
| 2022-11-23 | Perrin Steven | President | 1,000 0.0072% | $2.60 | $2,597 | -23.11% | ||
| 2021-12-20 | Gros David-Alexandre C | Chief Executive Officer | 2,000 0.0135% | $4.48 | $8,960 | -30.07% | ||
| 2021-08-17 | Gros David-Alexandre C | Chief Executive Officer | 4,000 0.0262% | $6.21 | $24,840 | -39.06% | ||
| 2021-06-11 | Little Paul Sean | CHIEF FINANCIAL OFFICER | 10,000 0.0681% | $8.87 | $88,700 | -46.53% | ||
| 2021-06-09 | Gros David-Alexandre C | Chief Executive Officer | 3,000 0.0203% | $8.01 | $24,030 | -40.88% | ||
| 2020-12-02 | Sale | OrbiMed Israel GP Ltd. | 10 percent owner | 103,200 6.5689% | $21.60 | $2.23M | -63.07% | |
| 2020-10-30 | Sale | Logos Global Management LP | 10 percent owner | 12,969 0.9094% | $26.64 | $345,559 | -62.38% | |
| 2020-10-30 | Logos Global Management LP | 10 percent owner | 92,040 6.1626% | $25.44 | $2.34M | -62.38% | ||
| 2019-05-21 | Sale | FLESHER GREGORY J. | Chief Executive Officer | 2,937 0.025% | $1.91 | $5,614 | -66.49% | |
| 2019-05-21 | Sale | TURKEL CATHERINE C. | President | 1,914 0.0163% | $1.91 | $3,658 | -66.49% | |
| 2019-05-21 | Sale | Kuwahara Jon | See Remarks | 1,058 0.009% | $1.91 | $2,022 | -66.49% | |
| 2019-05-20 | Sale | FLESHER GREGORY J. | Chief Executive Officer | 11,701 0.1045% | $1.96 | $22,953 | -65.78% | |
| 2019-05-20 | Sale | TURKEL CATHERINE C. | President | 7,623 0.068% | $1.96 | $14,953 | -65.78% | |
| 2019-05-20 | Sale | Kuwahara Jon | See Remarks | 4,218 0.0377% | $1.96 | $8,274 | -65.78% | |
| 2019-05-02 | OrbiMed Israel GP Ltd. | 646,204 6.2443% | $3.10 | $2M | -76.19% | |||
| 2019-05-02 | Chimovits Erez | director | 646,204 6.2443% | $3.10 | $2M | -76.19% | ||
| 2019-04-30 | Sale | LIFESCI INDEX PARTNERS LLC | 10 percent owner | 200 0.0017% | $2.70 | $540 | -75.47% | |
| 2018-09-12 | TURKEL CATHERINE C. | President | 16,632 0.1711% | $5.02 | $83,476 | -44.40% |
Insider Historical Profitability
| BVF PARTNERS L P/IL | 10 percent owner | 3361803 9.6306% | $2.54 | 2 | 0 | <0.0001% |
| Harrison Seth Loring | 7912079 32.6971% | $2.54 | 1 | 0 | ||
| Novartis Bioventures Ltd | 10 percent owner | 4493458 18.5695% | $2.54 | 1 | 9 | |
| Apple Tree Partners II - Annex, L.P. | 3568438 14.7468% | $2.54 | 1 | 0 | ||
| Chimovits Erez | director | 3183314 13.1552% | $2.54 | 1 | 0 | <0.0001% |
| Satter Muneer A | 10 percent owner | 1771688 7.3216% | $2.54 | 1 | 0 | |
| LIFESCI INDEX PARTNERS LLC | 10 percent owner | 1065867 4.4048% | $2.54 | 0 | 1 | |
| Logos Global Management LP | 10 percent owner | 224071 0.926% | $2.54 | 1 | 1 | <0.0001% |
| FLESHER GREGORY J. | Chief Executive Officer | 156918 0.6485% | $2.54 | 1 | 2 | |
| TURKEL CATHERINE C. | President | 88662 0.3664% | $2.54 | 4 | 2 | <0.0001% |
| OrbiMed Israel GP Ltd. | 10 percent owner | 73650 0.3044% | $2.54 | 1 | 1 | <0.0001% |
| Kalowski Lee | Chief Financial Officer | 40953 0.1692% | $2.54 | 0 | 4 | |
| OCAMPO CHRISTINE | See Remarks | 21590 0.0892% | $2.54 | 1 | 0 | |
| Morrison Jodie Pope | President and CEO | 19551 0.0808% | $2.54 | 0 | 3 | |
| Buckley Stephen Jr. | director | 11000 0.0455% | $2.54 | 2 | 0 | |
| Little Paul Sean | CHIEF FINANCIAL OFFICER | 10000 0.0413% | $2.54 | 1 | 0 | <0.0001% |
| Gros David-Alexandre C | Chief Executive Officer | 9000 0.0372% | $2.54 | 3 | 0 | <0.0001% |
| Kuwahara Jon | See Remarks | 5974 0.0247% | $2.54 | 0 | 2 | |
| Perrin Steven | President | 1000 0.0041% | $2.54 | 1 | 0 | <0.0001% |
| McBride John S. | Chief Operating Officer | 0 0% | $2.54 | 0 | 4 |
Institutional Investor Ownership
| Bvf Inc Il | $8.91M | 11.24 | 4.33M | 0% | +$0 | 0.07 | |
| Armistice Capital Llc | $4.73M | 5.97 | 2.3M | +4.93% | +$222,480.00 | 0.06 | |
| The Vanguard Group | $2M | 2.52 | 969,121 | +39.36% | +$563,828.11 | <0.0001 | |
| Woodline Partners LP | $1.34M | 1.69 | 651,939 | -5.43% | -$77,046.04 | 0.01 | |
| Ensign Peak Advisors Inc | $912,582.00 | 1.15 | 443,001 | 0% | +$0 | <0.01 | |
| Geode Capital Management | $372,783.00 | 0.47 | 180,901 | +2.76% | +$10,019.13 | <0.0001 | |
| Cm Management Llc | $329,600.00 | 0.42 | 160,000 | +14.29% | +$41,200.00 | 0.02 | |
| Susquehanna International Group | $205,543.00 | 0.26 | 99,778 | +15.59% | +$27,717.34 | <0.0001 | |
| Renaissance Technologies | $179,000.00 | 0.23 | 87,069 | +25.87% | +$36,791.33 | <0.0001 | |
| Jmac Enterprises Llc | $119,564.00 | 0.15 | 58,041 | 0% | +$0 | 0.02 | |
| Ingalls Snyder Llc | $107,000.00 | 0.14 | 51,849 | 0% | +$0 | 0.01 | |
| Schonfeld Group | $104,648.00 | 0.13 | 50,800 | New | +$104,648.00 | <0.01 | |
| State Street | $92,066.00 | 0.12 | 44,692 | 0% | +$0 | <0.0001 | |
| Northern Trust | $81,996.00 | 0.1 | 39,804 | -0.24% | -$197.76 | <0.0001 | |
| BlackRock | $55,272.00 | 0.07 | 26,831 | -5.2% | -$3,030.27 | <0.0001 | |
| Marco Investment Management Llc | $51,107.00 | 0.06 | 24,809 | New | +$51,107.00 | 0.01 | |
| Mercer Global Advisors Inc Adv | $34,000.00 | 0.04 | 16,726 | 0% | +$0 | <0.0001 | |
| Citadel Advisors LLC | $32,923.00 | 0.04 | 15,982 | -31.14% | -$14,885.60 | <0.0001 | |
| Charles Schwab | $30,873.00 | 0.04 | 14,987 | 0% | +$0 | <0.0001 | |
| Millennium Management LLC | $28,582.00 | 0.04 | 13,875 | -39.32% | -$18,523.20 | <0.0001 | |
| Tower Research Capital | $11,688.00 | 0.02 | 5,674 | +0.67% | +$78.28 | <0.0001 | |
| Morgan Stanley | $4,439.00 | 0.01 | 2,155 | 0% | +$0 | <0.0001 | |
| JPMorgan Chase | $115.00 | <0.01 | 56 | -94.34% | -$1,918.04 | <0.0001 | |
| UBS | $8.00 | <0.01 | 4 | -99.28% | -$1,104.00 | <0.0001 | |
| Fidelity Investments | $35.00 | <0.01 | 17 | New | +$35.00 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 40 | -62.96% | -$0 | <0.0001 | |
| Wells Fargo | $389.00 | <0.01 | 189 | +1.61% | +$6.17 | <0.0001 | |
| Group One Trading | $45.00 | <0.01 | 22 | 0% | +$0 | <0.0001 |